Results 11 to 20 of about 833,009 (242)

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial

open access: yesBrain : a journal of neurology, 2023
Therapeutics to reduce intracranial pressure are an unmet need. Preclinical data have demonstrated a novel strategy to lower intracranial pressure using glucagon-like peptide-1 (GLP-1) receptor signalling.
J. Mitchell   +11 more
semanticscholar   +1 more source

Clinical Presentation, Investigation Findings, and Treatment Outcomes of Spontaneous Intracranial Hypotension Syndrome

open access: yesJAMA Neurology, 2021
This systematic review and meta-analysis provides an objective summary of the available evidence on the clinical presentation, investigations findings, and treatment outcomes for spontaneous intracranial hypotension.
L. D’Antona   +6 more
semanticscholar   +1 more source

Case Report: Congenital Intracranial Kaposiform Hemangioendothelioma Treated With Surgical Resection

open access: yesFrontiers in Surgery, 2022
BackgroundKaposiform hemangioendothelioma (KHE) is a locally aggressive but non-metastatic vascular neoplasm. Most studies have been restricted to small case series of limited generalizability.
Yingjie Cai   +6 more
doaj   +1 more source

IL-1β and HMGB1 are anti-neurogenic to endogenous neural stem cells in the sclerotic epileptic human hippocampus

open access: yesJournal of Neuroinflammation, 2021
Background The dentate gyrus exhibits life-long neurogenesis of granule-cell neurons, supporting hippocampal dependent learning and memory. Both temporal lobe epilepsy patients and animal models frequently have hippocampal-dependent learning and memory ...
Malik Zaben   +5 more
doaj   +1 more source

Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension

open access: yesJAMA Neurology, 2021
Key Points Question Is bariatric surgery superior to a community weight management intervention in sustaining the weight loss necessary to achieve sustained remission among patients with idiopathic intracranial hypertension?
S. Mollan   +22 more
semanticscholar   +1 more source

Case report: Primary intracranial EWs/PNET in adults: Clinical experience and literature review

open access: yesFrontiers in Oncology, 2022
IntroductionAdult primary intracranial Ewing sarcomas (EWs)/primitive neuroectodermal tumors (PNETs) are extremely rare, with only 30 patients published before us.
Xianwen Hu   +5 more
doaj   +1 more source

Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis [PDF]

open access: yesJournal of Stroke, 2017
Background and Purpose Elevated blood pressure (BP) is associated with greater severity of intracranial atherosclerotic stenosis (ICAS) and increased risk of ischemic stroke.
Jong-Ho Park   +3 more
doaj   +1 more source

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

open access: yesClinical Cancer Research, 2021
Purpose: We report the intracranial efficacy of selpercatinib, a highly potent and selective RET inhibitor, approved in the United States for RET fusion-positive non–small cell lung cancers (NSCLC).
V. Subbiah   +20 more
semanticscholar   +1 more source

MRI evidence for altered venous drainage and intracranial compliance in mild traumatic brain injury. [PDF]

open access: yes, 2013
To compare venous drainage patterns and associated intracranial hydrodynamics between subjects who experienced mild traumatic brain injury (mTBI) and age- and gender-matched controls.
Alperin, Noam   +7 more
core   +7 more sources

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

open access: yesJournal of Clinical Oncology, 2020
PURPOSE In the HER2CLIMB study, patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer with brain metastases (BMs) showed statistically significant improvement in progression-free survival (PFS) with tucatinib.
N. Lin   +28 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy